Bionorica SE

Quick facts

Phase 3 pipeline

• BNO 1016 · Respiratory / Pulmonology
  BNO 1016 is a herbal combination product that modulates immune and inflammatory responses to support respiratory health.
• BX-1 · Respiratory/Immunology
  BX-1 is a herbal extract combination that modulates immune and inflammatory pathways to support respiratory and immune function.
• Canephron® N · Urology / Nephrology
  Canephron N is a herbal combination that reduces inflammation and supports kidney and urinary tract function through diuretic and antimicrobial properties.
• Placebo coated tablets
  Placebo coated tablets contain no active pharmaceutical ingredient and work through the placebo effect, where the expectation of treatment produces therapeutic benefit independent of pharmacological action.
• Sinupret extract coated tablets · Otolaryngology / Respiratory
  Sinupret extract is a herbal combination that reduces inflammation and promotes drainage in the sinuses and respiratory tract.
• VAC BNO 1095 film coated tablets · Immunology / Respiratory / Inflammation
  VAC BNO 1095 is a herbal film-coated tablet formulation that modulates immune and inflammatory responses through its botanical active constituents.

Phase 2 pipeline

• administration of Bronchipret
• administration of Sinupret

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Bionorica SE portfolio CI brief
• Bionorica SE pipeline updates RSS